Overview

Extremely Low Gestatonal Age Infants' Paracetamol Study

Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
In the present trial, early, intravenous paracetamol is compared to placebo in extremely premature or low birth weight infants in order to evaluate the effect on ductal closure.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Outi Aikio
Treatments:
Acetaminophen
Pharmaceutical Solutions